ArticleJournal of the American Academy of Orthopaedic Surgeons. Global research & reviews2026
Postoperative Intravenous Ketorolac Does Not Affect Nonunion Risk in Surgically Treated Long Bone Shaft Fractures.
Article in Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNonsteroidal anti-inflammatory drugs (NSAIDs) have become an increasingly important component of orthopaedic pain management protocols in an effort to reduce dependence on opioids. However, concerns remain regarding their potential impact on fracture healing. Ketorolac is a potent NSAID commonly administered postoperatively in orthopaedic surgery, but its effects on nonunion rates remain unclear. This study aims to evaluate whether short-term postoperative intravenous (IV) ketorolac administration is associated with an increased risk of nonunion or nonunion-related revision surgery in patients undergoing surgical fixation of long bone fractures.
methodsA retrospective cohort analysis was done using the TriNetX database. Adult patients who underwent surgical fixation of femoral, tibial, humeral, radial, or ulnar shaft fractures between 2003 to 2023 were included. Patients with infection, open fractures, or a history of nonunion were excluded. Cohorts were defined based on postoperative IV ketorolac use within 5 days of surgery. After 1:1 propensity score matching for demographics and comorbidities, nonunion and revision surgery rates were compared using odds ratios (ORs) with 95% confidence intervals (CIs). Subgroup analyses were done by fracture type and age group.
resultsA total of 14,951 matched patients (7464 ketorolac; 7487 no ketorolac) were analyzed. No notable differences in nonunion rates were observed between the ketorolac and no ketorolac groups overall (2.2% vs 1.9%; OR 1.187 [95% CI, 0.941 to 1.498]) or within the tibial, femoral, or humeral subgroups. Ulnar and radial shaft fractures lacked sufficient sample sizes for subgroup analysis. Revision surgery rates were likewise comparable between the groups (1.2% vs 1.1%; OR 1.094 [95% CI, 0.803 to 1.491]). Age-stratified analyses showed no increased risk across age groups (18 to 29, 30 to 64, ≥65 years).
conclusionsPostoperative administration of IV ketorolac within 5 days of surgery does not increase the odds of nonunion or nonunion-related revision surgery for femoral, tibial, or humeral shaft fractures in low-risk adults. These findings support the use of short-duration IV ketorolac as part of multimodal analgesia protocols in postoperative fracture care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.